However, germline Bace1-null mice exhibit increased seizures and epileptiform spiking on EEG, and global inhibition of BACE1 alone has failed to improve cognitive functions in patients with AD (Das and Yan, 2019; McDade et al., 2021), indicating a need to refine and optimize this therapeutic strategy. Here, BACE1 is linked to Alzheimer disease.